RAPID • NONINVASIVE • POINT OF CARE
Early, rapid, non-invasive pre-screening tools will stop the spread of COVID-19 by identifying infected individuals.
For years our company, Tiger Tech, has been developing wearable sensor systems and researching disease state identification. On April 9, we knew that we had to help the world find an innovative solution for COVID-19 screening and testing.
"SUCCESSFULLY IDENTIFIES ASYMPTOMATIC SUBJECTS"
After years of research on disease states and months of research, on 1,000s of COVID subjects, our company developed a device called the COVID Plus: an armband with embedded sensors that acquire biometric signals from the body. This device is completely noninvasive. Over a period of 3 to 5 minutes, the COVID Plus Monitor checks for abnormalities in a
"TRACKS DISEASE PROGRESSION & INFECTIOUSNESS"
participant's biometrics, along with other COVID-19 complications.
The device uses hundreds of unique biomarkers to find patterns associated with COVID-19. This is a very similar process to facial pattern recognition programs that are used to unlock phones.
Positive and negative results are based on statistical analysis, specifically, the device analyzes where a user's biomarkers are positioned relative to thousands of COVID and NON-COVID subjects. Most importantly, these markers are present in COVID asymptomatic subjects.
The Tiger Tech COVID Plus is a game changer that will help stop the spread of COVID-19.
MEET THE COVID PLUS
The COVID Plus was developed by a team of physicians and engineers at one of the largest hospitals in the United States, Mount Sinai Medical Center (MSMC) in Miami Beach, Florida.
The COVID Plus excels in identifying asymptomatic COVID positive subjects.
The COVID Plus takes less than 3 to 5 minutes to render a decision.
Features a red or green indication.
Does not require historical data or cloud computing, protecting your health information.